BrilliA Announces Six-month Earnings of $0.06 per Share and a 17% Revenue Increase for the Six Months Ended September 30, 2024 Read more
HUTCHMED Announces NMPA Conditional Approval for TAZVERIK® (tazemetostat) for the Treatment of Relapsed or Refractory Follicular Lymphoma Read more
Foresight Ventures Latest Stablecoin Overview: Why Non-Crypto Users Are the Next Frontier for Stablecoin Integration Read more
The 2025 Wuxi “International Month” and International Cherry Blossom Viewing Week grandly open Read more
Sunlands Technology Group Announces Unaudited Fourth Quarter and Full Year 2024 Financial Results Read more
Mercurity Fintech Subsidiary Chaince Securities, LLC Receives FINRA Approval for Continuing Membership Application (CMA) Read more
Myth of Empires — Xizhou Civilization DLC Available Now on Steam with a Limited-Time 10% Discount Read more